The observed upregulation of vimentin in carboplatin and to a lesser extent paclitaxel resistant mesenchymal-like TNBC cells and a reduction in the expression of EpCAM in carboplatin and paclitaxel treated epithelial tumor cells is consistent with invasive tendencies for TNBC cells following treatment with chemotherapy agents (37). Here, EPCAM is linked to neoplasm.